Hear from EACPT Madrid Congress delegates from Spain, Turkey, Sweden, the UK, Romania and Brazil

The 12th biennial Congress of the European Association for Clinical Pharmacology and Therapeutics (http://eacpt.eu) was held in Madrid from 27th to 30th June 2015. Over 500 abstracts have been accepted for presentation as e-posters. 54 oral presentations were eligible for an award for the best talk. In this recording, young clinical pharmacologists from Spain discuss their careers, the EACPT and its latest Congress in Madrid with EACPT Secretary Donald Singer.

Hear from Clinical Pharmacologists in training and in established posts from Spain, Turkey, Sweden, the UK, Romania and Brazil in discussion with Donald Singer, EACPT.

Below: delegates at the Madrid Conference from France, UK, Spain, Denmark, South Korea, Serbia, Venezuela, Uruguay, Romania and Brazil.

Cristina Pop and Cristina Ionela Mogosan, Romania

Prof Helena Barros and Prof Mário Tannhauser, Porto Alegre, Brazil

Meet members of the new EACPT Board of International Consulting Editors

A meeting of members of the EACPT Board of International Consulting Editors (BICE) was held during the EACPT Congress in Madrid. The 12th biennial Congress of the European Association for Clinical Pharmacology and Therapeutics (http://eacpt.eu) was held in Madrid from 27th to 30th June 2015. Over 500 abstracts were accepted from 66 countries and from all 5 continents for presentation as e-posters and oral presentations. 54 oral presentations were eligible for best talk awards.

Hear from some of the EACPT BICE members: Jozef Glasa (Slovak Republic), Romuald Bellman (Austria), Sinem Ezgi Gulmez (France), Alexander Khokhlov (Russia) and Dr Marie Besson (Switzerland) in discussion with Donald Singer (EACPT). 

The official journal of the EACPT is Clinical Therapeutics, published by Elsevier: Editor-in-Chief - Dr Richard Shader 

Full list of EACPT BICE members:
- Romuald Bellman, Innsbruck Medical University, Innsbruck, Austria 
- Marie Besson, Geneva University Hospitals, Switzerland 
- Bernard Cheung, Queen Mary Hospital, Hong Kong 
- Emilio Clementi, University of Milan, Italy 
- Jozef Glasa, Slovak Medical University, Bratislava, Slovakia 
- Sinem Ezgi Gulmez, University of Bordeaux, France
- Maria Theresa Herdeiro, University of Aveiro, Portugal 
- Alexander Khokhlov, Clinical Hospital, Yaroslavl State Medical University, Russia 
- Adrián Llerena, Clinical Research Center University Hospital, Badajoz, Spain 
- Stefan Oswald, University of Greifswald, Germany

Pharmacogenetics in clinical practice discussed at EACPT Madrid Congress

Implementation of pharmacogenetics and personalised medicine in clinical practice was the focus of one of the key sessions of the EACPT Congress in Madrid. In this video, Matthias Schwab (Germany), Edoardo Spina (Italy), Marja-Liisa Dahl (Sweden), Adrián LLerena (Spain) and Ingolf Cascorbi (Germany) discuss pharmacogenetics in clinical practice from a healthcare perspective, clinical vs. business need and pharmacoeconomic evaluation of pharmacogenomics in healthcare systems.   

Listen to the panel discuss pharmacogenetics.


The 12th biennial Congress of the European Association for Clinical Pharmacology and Therapeutics (http://eacpt.eu) was held  in Madrid from 27th to 30th June 2015. Over 500 abstracts were accepted from 66 countries and from all 5 continents for presentation as e-posters and oral presentations. The 54 oral presentations were eligible for awards for  best talks. 

Progress on research on treatments for Alzheimer's discussed at EACPT Madrid Congress

The 12th biennial Congress of the European Association for Clinical Pharmacology and Therapeutics (http://eacpt.eu) was held  in Madrid from 27th to 30th June 2015. Over 500 abstracts were accepted from 66 countries and from all 5 continents for presentation as e-posters and oral presentations. the 54 oral presentations were eligible for awards for the best talks. 

Hear more about Alzheimer's disease and new ways to develop treatments on our YouTube channel video.

 
Alzheimer's disease was the focus of one of the key sessions of the Congress. Claudio Babiloni (Italy), David Bartrés-Faz (Spain), Régis Bordet (France) and Pablo Martinez-Lage (Spain) have been discussing

Claudio Babiloni, David Bartrés-Faz, Régis Bordet and Pablo Martinez-Lage

available treatments, why previous treatment approaches may not have worked, new biomarkers of response to treatment and a major international consortium of academic and clinical researchers and 12 pharmaceutical companies interested in better ways to move forward on successful drug development.

Madrid EACPT Masterclass by EACPT official journal editor Richard Shader on how to publish in scientific journals

The 12th biennial Congress of the European Association for Clinical Pharmacology and Therapeutics (http://eacpt.eu) was held in Madrid from 27th to 30th June 2015. Over 500 abstracts were accepted from 66 countries and from all 5 continents for presentation as e-posters and oral presentations. the 54 oral presentations were eligible for an award for the best talk. 

At a well-attended EACPT Congress session, EACPT official journal editor Richard Shader gave a Masterclass to over 80 delegates on how publish a scientific paper.

Listen to Dr Shader discussing Clinical Therapeutics with Donald Singer from the EACPT:

Dr Shader's key messages on scientific writing included

- write clearly
- explain why you undertook the work
- describe how you advanced knowledge in the field.
- note further work that would take the field forward
- decide title and write abstract last - avoid excessive use of adverbs  
 - use short sentences
- consider use of translation support if English is not your first language: this should be translation of your own text, NOT ghost writing

More helpful advice for authors

The European Association of Clinical Pharmacology and Therapeutics has Clinical Therapeutics as its Official Journal, in partnership with the major international publisher Elsevier. 

The journal features highlights of EACPT scientific and other activities and provides information on future EACPT congresses, summer schools and other events. The journal  also publishes peer-reviewed original papers and reviews arising from EACPT conferences. 

2015 EACPT Scientific Award and Joint EACPT-EPHAR Translational Pharmacology Awards

The 12th biennial Congress of the European Association for Clinical Pharmacology and Therapeutics (http://eacpt.eu) was held in Madrid from 27th to 30th June 2015. Over 500 abstracts were accepted from 66 countries and from all 5 continents for presentation as e-posters and oral presentations. The 54 oral presentations were eligible for awards for best talks. The 2015 EACPT Scientific Award and Joint EACPT-EPHAR Translational Pharmacology Awards were presented at the end of June at the EACPT Congress in Madrid.

Listen to these 2015 EACPT Award winners discussing the research which led to their awards.


EACPT Scientific Award was conferred on UK Scientist Professor Nicholas Bateman for work on treating paracetamol overdose. The EACPT Scientific Award, which includes a prize of 2000€, was presented to Professor Bateman at the 12th EACPT Congress in Madrid in June 2015. 

The inaugural EACPT-EPHAR Young Investigator Awards in Translational Pharmacology have been conferred on PhD student Christoph Schneider from Bern in Switzerland and Dr Daniel Antoine from Liverpool in the UK.

Donald Singer (EACPT EC), Nicholas Bateman and Tabassome Simon (EACPT Chair)

Professor Bateman's research, which was published in the international medical journal The Lancet, involved a clinical trial comparing a new regimen to treat paracetamol poisoning with the current one (which has been used for over 40 years). It is the first large-scale, properly powered and randomised controlled clinical trial conducted in paracetamol poisoning, a challenging environment for trial work. 

The Federation of European Pharmacology Societies (EPHAR) and the European

Thomas Griesbacher (EPHAR President), Christoph Schneider, Dr Daniel Antoine, Tabassome Simon (EACPT Chair)

Association for Clinical Pharmacology and Therapeutics (EACPT) developed the above Young Investigator joint initiative to recognise projects of excellence in translational research in pharmacology. 2 awards of EUR 1,000 each were given EACPT Congress in Madrid to Christoph Schneider and Dr Daniel Antoine for their recent outstanding research papers. 

Requirements for the EACPT-EPHAR Young Investigator Awards in Translational Pharmacology are that applicants must be not more than 35 years of age on the deadline date, have as first author published an outstanding paper in the 2 years prior to the Awards, have conducted the submitted study in an institution of a country member of EACPT and/or EPHAR; and be a member of one of the member societies of EPHAR or EACPT, or be an individual associate member of EACPT.

Trainees from Czech Republic, USA and Uruguay comment on the Madrid EACPT Congress.

Listen to clinical pharmacologists in training from the Czech Republic, USA and Uruguay comment on the Madrid Congress.

 

The 12th biennial Congress of the European Association for Clinical Pharmacology and Therapeutics (http://eacpt.eu) was held in Madrid from 27th to 30th June 2015. Over 500 abstracts were accepted from 66 countries and form all 5 continents for presentation as e-posters and oral presentations. The 54 oral presentations were eligible for awards for best talks.

Drug information and decision support for rational drug treatment

Linda Amundstuen Reppe, Ylva Böttiger and Robert Van der Stichele

The 12th biennial Congress of the European Association for Clinical Pharmacology and Therapeutics (http://eacpt.eu) was underway in Madrid from 27th to 30th June 2015. Over 500 abstracts were accepted from 66 countries and from all 5 continents for presentation as e-posters and oral presentations. the 54 oral presentations were eligible for an award for the best talk. 

Listen to Robert Van der Stichele (Belgium), Ylva Böttiger (Sweden) and Linda Amundstuen Reppe (Norway) in discussion with Donald Singer (EACPT) about drug information and decision support for rational drug treatment.